About this episode

This episode discusses the potential role of the thymus as a marker of biological ageing and its implications for health risks and cancer treatment outcomes.

🧬 Could the thymus be an overlooked marker—and perhaps future target—of biological ageing? This Nature feature highlights evidence linking smaller or absent thymic tissue with higher risks of death, cancer, cardiovascular disease, and poorer outcomes after cancer immunotherapy. 🔬 Regeneration strategies are advancing, but the evidence remains largely correlational. 💡 Clinical pearl: thymic involution may reflect declining immune reserve, yet no rejuvenation therapy is ready for routine care.

People in this episode

Host: Dr RR Baliga

Topics covered

• thymus
• biological ageing
• cancer
• cardiovascular risk
• immune system
• regeneration strategies

Keywords

• thymus
• biological ageing
• cancer
• cardiovascular risk
• immune reserve
• thymic involution
• regeneration strategies

Mentioned in this episode

Organizations: Nature

More episodes of Dr RR Baliga's "Got Knowledge Doc" Podkast

• Great Doctors Series: Zhang Zhongjing—China's Medical Sage · July 21, 2026 · 2 min
• 🩺 Can dual antithrombotic therapy after PCI be safely shortened to just 1 month in patients with atrial fibrillation? · July 20, 2026 · 3 min
• 💊 Twelve More Months of DAPT, Fewer Heart Attacks, No Extra Bleeding · July 19, 2026 · 2 min
• 🛡️ Fountain of Youth, Immune Truth: EP2 Flips the Healthy Aging Switch · July 18, 2026 · 2 min
• 🍏 Whole Fruit Wins: Rethinking Fructose and Blood Pressure · July 17, 2026 · 2 min
• 🧠 Blood p-Tau217: 🩸 A Blood Test That Sees Dementia Coming · July 16, 2026 · 2 min

Explore listener stats, chart rankings, contacts and more on the Dr RR Baliga's "Got Knowledge Doc" Podkast podcast page.